DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Abrams P, Kelleher C, Staskin D. et al.
Combination Treatment with Mirabegron and Solifenacin in Patients with Overactive Bladder: Efficacy and Safety Results from a Randomised, Double-blind, Dose-ranging, Phase 2 Study (Symphony).
Eur Urol 2015;
67: 577-588
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.